ArticleCancer medicine2020
Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns.
Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 23 citations in OpenAlex.
- Effects of message framing on HPV Vaccination decision-making: A Survey experiment among Chinese male college students.Human vaccines & immunotherapeutics · 2026Article
- Vaccination-Related Applications and Health Care Professionals' Observed Changes in Human Papillomavirus Vaccine Hesitancy: Cross-Sectional Survey.JMIR mHealth and uHealth · 2026Article
- Examining Artificial Intelligence Chatbots' Responses in Providing Human Papillomavirus Vaccine Information for Young Adults: Qualitative Content Analysis.JMIR public health and surveillance · 2026Article
- Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health.International journal for equity in health · 2025Review
- Analysis of factors driving HPV vaccination coverage and associated cost savings in the united States.BMC public health · 2025Article
- Article
- Barriers to child vaccination: The role of international sanctions.SSM - population health · 2024Article
- Article
- Article
- Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.Frontiers in oncology · 2024Review
- Reasons patients cite to their health-care professional for not initiating or completing human papillomavirus vaccination.JNCI cancer spectrum · 2023Article
- Article
- Relation of Personal Characteristics with Human Papillomavirus Vaccination Outcomes: Assessing the Mediating Role of Vaccine Hesitancy Dimensions.International journal of sexual health : official journal of the World Association for Sexual Health · 2023Article
- Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review.Open forum infectious diseases · 2023Review
- Parents' Acceptance of COVID-19 Compared to Human Papillomavirus Vaccines.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2022Article
- Health literacy and its association with human papilloma virus vaccination among adults: Findings from the behavioral risk factor surveillance system.Human vaccines & immunotherapeutics · 2022Article
- HPV Vaccination Training of Healthcare Providers and Perceived Self-Efficacy in HPV Vaccine-Hesitancy Counseling.Vaccines · 2022Article
- Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns.Cancer medicine · 2020Article
- "If People Were Told About the Cancer, They'd Want to Get Vaccinated": Knowledge, Attitudes, and Beliefs About HPV Vaccination Among Mid-Adult Men.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThe upward trends of vaccine exemptions in Texas are alarming. While HPV vaccine rates in this State are among the lowest nationwide, factors that contribute to the low HPV vaccination uptake among adults remain unknown. In this study, we examined the main reasons for not receiving HPV vaccination among age-eligible adults.
methodsThe Texas health screening survey (2018), a multistage area probability design-based survey of a representative sample of Texas residents, was used to identify 907 eligible adults (age ≥ 18 years) respondents, including 724 women aged ≤ 26 years in 2007 (≤38 years in 2018), and 183 men aged ≤ 21 years in 2011 (≤28 years in 2018). Participants who reported having never received an HPV shot, where asked the main reason for not receiving the vaccine.
resultsOverall, 58.5% (95%CI: 55.1-62.0) of vaccine eligible adults reported having never received the HPV vaccine. The most commonly reported reasons for not receiving it were: did not know about the vaccine (18.5% (14.9-22.1)), and provider did not recommend (14.1% (10.9-17.4)). In contrast, commonly perceived reasons such as: safety concerns (7.2% (4.8-9.5)), lack of insurance (3.4% (1.7-5.1), and concerns about increasing sexual activity if vaccinated (0.2% (0.0-0.5)), were less frequently reported.
conclusionAmong vaccine-eligible adults, safety and sexuality concerns do not appear to be the prime factors underlying low HPV vaccination rates. Rather than emphasizing them, educational interventions should aim at improving vaccine's knowledge, and enhancing provider recommendations on the necessity of HPV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.